Tonight on Nightly Business Report, Apple reports strong quarterly results and announces a huge stock split. Is it a good move for investors? And, Coke shareholders approve its controversial executive pay package. Tonight, Warren Buffett, Coca-Cola’s biggest shareholder, reacts to the vote.
Apple reports strong quarterly results and announces a huge stock split. Is it a good move for investors?
U.S. stocks declined on Wednesday, with Wall Street retreating after a sixth day of gains for the S&P 500 and Nasdaq, after data had new home sales declining in March and companies including Boeing and AT&T reported quarterly results. “The market is — I don’t want to say bracing — but waiting for something to develop one way or …
Less-educated Americans desperate for work may not be finding a job online for one simple reason: The job they want isn’t being posted there. A new analysis of online job postings, released Wednesday by Georgetown University’s Center on Education and the Workforce, finds that most jobs for people with a college education are now posted …
It’s not only Uncle Sam that needs money. State governments also collect tax revenues—even the seven that don’t have a state income tax. But some of them do a better job at giving taxpayers a bang for their buck—or to put it into Wall Street terminology, give better return on investment (ROI). Read More 5 ways to cut …
It’s been hard enough teaching people how to save for their retirement. It could be even more difficult to teach them how to spend that nest egg. As the multi-trillion dollar 401(k) industry becomes the predominant way that many Americans finance their golden years, millions of retirees are going to have to make big, complex decisions about …
Activist investor Bill Ackman told CNBC on Wednesday his partnership with Valeant Pharmaceuticals to try to buy Allergan for $46 billion does not violate securities law. This arrangement, in which Ackman bought a 9.7 percent stake in the Botox maker at the behest of Valeant, was not front-running and not insider trading, Ackman said in a “Squawk Box” interview. …
It is so dry in California that the U.S. Department of Agriculture recently reported that 94 percent of the state’s massive $45 billion farm economy is suffering from severe to “exceptional” drought. That could change—dramatically. “The odds are stacked that we will see a return for the first time in five years to El Niño …
Citigroup executives were expected to come under intense scrutiny from shareholders today, who wanted to hear more about company’s recent stumbles, including the failed stress test an allegations of fraud at its Mexican banking unit. But as Kayla Tausche reports from St. Louis, the meeting turned out better than expected.
The fate of a small TV streaming company facing its accusers in a Supreme Court case this week could have big implications for how consumers experience live, streaming TV content over the Internet. Subscription service Aereo is being accused by the likes of ABC, CBS, NBC, and Fox of illegally acquiring and re-transmitting copyrighted broadcasts …
It was a different story at another Dow company, McDonald’s releasing first quarter earnings. Along with March sales figures, before the bell today and both of them disappointed investors. Shares of McDonald’s were among the biggest decliners among the blue chips today, falling by a third of one percent. Courtney Reagan takes a closer look …
U.S. stocks rose on Tuesday, with the S&P 500 extending its longest winning run of the year, as investors considered earnings from companies including McDonald’s and Netflix along with a roughly $45 billion offer for Allergan. “We’ve had some high-profile deals in the health care sector that have folks excited, and we’ve had some good earnings numbers, which is motivating …
Are all of the recent pharmaceutical deals part of a broader merger boom?
First there were rumors surrounding AstraZeneca, then Botox-maker Allergan was caught in a takeover storm and on Tuesday GlaxoSmithKline (GSK) and Novartis announced a $16 billion commercial tie-up. The pharmaceutical industry has been swept up in a wave of mergers and acquisitions. Industry observers have been waiting for a rush of deals for months, as cash-rich companies work to reshape themselves. And …
